What it is
Apigenin is a flavonoid abundant in chamomile — arguably the molecule behind the tea's centuries-old reputation. It binds benzodiazepine sites on GABA-A receptors, the same receptor family prescription sedatives target, with far less force and without their dependency profile. That mechanism predicts exactly the effect a sleep formula wants from it: quieter mental noise, easier descent into sleep.
What the research used
Human sleep work with apigenin is early-stage and frequently embedded in combination formulas, making attribution fuzzy; the doses circulating in the popular literature cluster around 50 mg nightly. Chamomile-extract trials report modest sleep-quality improvements. Animal and receptor work is stronger than the human record — the classic "promising, preliminary" shape.
Evidence strength: early
Mechanism: compelling. Human trials: small, short, often combined. Tier: early.
Inside YU Sleep
Third-listed in the blend, apigenin sits in a plausible position for a tens-of-milligrams dose if the blend skews top-heavy — but "if" is doing real work in that sentence. Its role in the formula reads as calm-lane reinforcement alongside lemon balm and GABA: three gentle touches on the same receptor system, a stacking philosophy that makes sense if you accept gentle as the goal.
Practical read
Apigenin enthusiasts can get it the old way — a cup of decent chamomile an hour before bed costs pennies and adds ritual value the capsule can't. Inside YU Sleep, treat it as one vote for the calm lane, not a headline act.